首页 | 本学科首页   官方微博 | 高级检索  
     


Mortality and Implant Survival With Simultaneous and Staged Bilateral Total Hip Arthroplasty: Experience From the Australian Orthopedic Association National Joint Replacement Registry
Affiliation:1. Instituite of Health and Biomedical Innovation (IHBI), Queensland University of Technology (QUT), Brisbane, Queensland, Australia;2. The Prince Charles Hospital (TPCH), Department of Orthopaedic Surgery, Chermside, Queensland, Australia;3. South Australian Health and Medical Research Institute (SAHMRI), Adelaide, South Australia, Australia;4. Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR), Adelaide, South Australia, Australia;5. Department of Surgery, Epworth Healthcare, University of Melbourne, Melbourne, Victoria, Australia;1. Levitetz Department of Orthopaedic Surgery, Cleveland Clinic Florida, Weston, FL;2. Miami Orthopedics & Sports Medicine Institute, Baptist Health South Florida, Miami, FL;1. Scunthorpe General Hospital, United Kingdom;2. Keele University, United Kingdom;1. Department of Veterans’ Affairs, 300 Elizabeth Street, Sydney 2000, Australia;2. School of Public Health, Edward Ford Building (A27), University of Sydney, NSW 2006, Australia;1. Department of Orthopaedic Surgery, Division of Adult Reconstruction and Joint Replacement, Hospital for Special Surgery, Weill Medical College of Cornell University, New York, New York;2. Department of Anesthesiology, Hospital for Special Surgery, Weill Medical College of Cornell University, New York, New York;3. Epidemiology and Biostatistics Core, Hospital for Special Surgery, Weill Medical College of Cornell University, New York, New York;1. Department of Orthopedics, Hospital for Special Surgery, New York, NY;2. Department of Biostatistics, Hospital for Special Surgery, New York, NY
Abstract:BackgroundTotal hip arthroplasty (THA) is an effective procedure for relieving pain and restoring function in osteoarthritis. A significant proportion of patients have severe disease bilaterally. Consensus regarding safety and selection of patients for simultaneous bilateral THA or the optimal timing for staged THA has not been reached. The aim of this study is to compare rates, causes of revision, and 30-day mortality between simultaneous and staged bilateral THA using data from the Australian Orthopedic National Joint Replacement Registry.MethodsData for 12,359 bilateral THA procedures were collected from September, 1999 to December, 2017. Rates and causes of revision and 30-day mortality were obtained for simultaneous bilateral and staged procedures with intervals of 1 day-6 weeks, 6 weeks-3 months, and 3 months-6 months. Yearly cumulative percent revision or cumulative percent survival with 95% confidence intervals calculated by the Kaplan-Meier method, and adjusted hazard ratios were used for comparisons.ResultsThirty-day mortality is lower in patients who have bilateral procedures within 6 months, regardless of timing, than those who have unilateral procedures (0.06% vs 0.18%). Staged bilateral THA had a significantly lower mortality than simultaneous bilateral THA (odds ratio 0.175, 95% confidence interval = 0.04-0.78, P = .022). When separate time intervals were compared, no significant differences were seen. Bilateral 6 week-3 months has a higher rate of revision from 1.5 years-2years compared with same day bilaterals (hazard ratio = 2.39, 95% confidence interval = 1.12, 5.09, P = .024). There were no other significant differences in the rate of revision between groups.The most common reasons for revision were fracture, loosening, and infection. Simultaneous bilateral procedures have a significantly higher rate of revision for fracture compared with staging 3-6 months (hazard ratio = 1.96 [1.27, 3.03], P = .002).ConclusionThis study demonstrates that bilateral THA has a low mortality rate regardless of time interval between procedures. Simultaneous and staged bilateral THA have similar rates of revision.
Keywords:registry  hip replacement  arthroplasty  bilateral  mortality  survivorship  revision
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号